BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38322888)

  • 1. HuaChanSu suppresses the growth of hepatocellular carcinoma cells by interfering with pentose phosphate pathway through down-regulation of G6PD enzyme activity and expression.
    Wu Q; Ge XL; Geng ZK; Wu H; Yang JY; Cao SR; Yang AL
    Heliyon; 2024 Feb; 10(3):e25144. PubMed ID: 38322888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HuaChanSu suppresses tumor growth and interferes with glucose metabolism in hepatocellular carcinoma cells by restraining Hexokinase-2.
    Wu Q; Wang SP; Sun XX; Tao YF; Yuan XQ; Chen QM; Dai L; Li CL; Zhang JY; Yang AL
    Int J Biochem Cell Biol; 2022 Jan; 142():106123. PubMed ID: 34826616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis.
    Hong X; Song R; Song H; Zheng T; Wang J; Liang Y; Qi S; Lu Z; Song X; Jiang H; Liu L; Zhang Z
    Gut; 2014 Oct; 63(10):1635-47. PubMed ID: 24352616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A feedback loop of PPP and PI3K/AKT signal pathway drives regorafenib-resistance in HCC.
    Yang H; Chen D; Wu Y; Zhou H; Diao W; Liu G; Li Q
    Cancer Metab; 2023 Dec; 11(1):27. PubMed ID: 38111012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
    Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
    J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Emerging Roles of the Metabolic Regulator G6PD in Human Cancers.
    Ahamed A; Hosea R; Wu S; Kasim V
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pentose phosphate pathway regulates chronic neuroinflammation and dopaminergic neurodegeneration.
    Tu D; Gao Y; Yang R; Guan T; Hong JS; Gao HM
    J Neuroinflammation; 2019 Dec; 16(1):255. PubMed ID: 31805953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLK1 regulating chemoradiotherapy sensitivity of esophageal squamous cell carcinoma through pentose phosphate pathway/ferroptosis.
    Zhao M; Lu T; Bi G; Hu Z; Liang J; Bian Y; Feng M; Zhan C
    Biomed Pharmacother; 2023 Dec; 168():115711. PubMed ID: 37879213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated G6PD expression contributes to migration and invasion of hepatocellular carcinoma cells by inducing epithelial-mesenchymal transition.
    Lu M; Lu L; Dong Q; Yu G; Chen J; Qin L; Wang L; Zhu W; Jia H
    Acta Biochim Biophys Sin (Shanghai); 2018 Apr; 50(4):370-380. PubMed ID: 29471502
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Kanwal L; Ali S; Rasul A; Tahir HM
    Saudi J Biol Sci; 2022 Oct; 29(10):103400. PubMed ID: 35991850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting glucose-6-phosphate dehydrogenase by 6-AN induces ROS-mediated autophagic cell death in breast cancer.
    Li Y; Zheng F; Zhang Y; Lin Z; Yang J; Han X; Feng Y; Pei X; Li F; Liu Q; Yan L; Li T; Zhang Y; Li D; Fu Z; Wang C; Sun Q; Li C
    FEBS J; 2023 Feb; 290(3):763-779. PubMed ID: 36048131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated activity of the oxidative and non-oxidative pentose phosphate pathway in (pre)neoplastic lesions in rat liver.
    Frederiks WM; Vizan P; Bosch KS; Vreeling-Sindelárová H; Boren J; Cascante M
    Int J Exp Pathol; 2008 Aug; 89(4):232-40. PubMed ID: 18422600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhubarb granule promotes diethylnitrosamine-induced liver tumorigenesis by activating the oxidative branch of pentose phosphate pathway via G6PD in rats.
    Huang H; Liu Z; Qi X; Gao N; Chang J; Yang M; Na S; Liu Y; Song R; Li L; Chen G; Zhou H
    J Ethnopharmacol; 2021 Dec; 281():114479. PubMed ID: 34343647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of non-small cell lung cancer (NSCLC) proliferation through targeting G6PD.
    Chanda M; Anuntasomboon P; Ruangritchankul K; Cheepsunthorn P; Cheepsunthorn CL
    PeerJ; 2023; 11():e16503. PubMed ID: 38077440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer.
    Barajas JM; Reyes R; Guerrero MJ; Jacob ST; Motiwala T; Ghoshal K
    Sci Rep; 2018 Jun; 8(1):9105. PubMed ID: 29904144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection by glucose-6-phosphate dehydrogenase and the pentose phosphate pathway.
    Tang BL
    J Cell Biochem; 2019 Sep; 120(9):14285-14295. PubMed ID: 31127649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zoledronic acid inhibits the pentose phosphate pathway through attenuating the Ras-TAp73-G6PD axis in bladder cancer cells.
    Wang X; Wu G; Cao G; Yang L; Xu H; Huang J; Hou J
    Mol Med Rep; 2015 Sep; 12(3):4620-4625. PubMed ID: 26126921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Transcription Coregulator RIP140 Inhibits Cancer Cell Proliferation by Targeting the Pentose Phosphate Pathway.
    Jacquier V; Gitenay D; Cavaillès V; Teyssier C
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-6-phosphate dehydrogenase and transketolase: Key factors in breast cancer progression and therapy.
    Zhen X; Zhang M; Hao S; Sun J
    Biomed Pharmacother; 2024 Jun; 176():116935. PubMed ID: 38876050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose 6-P Dehydrogenase-An Antioxidant Enzyme with Regulatory Functions in Skeletal Muscle during Exercise.
    García-Domínguez E; Carretero A; Viña-Almunia A; Domenech-Fernandez J; Olaso-Gonzalez G; Viña J; Gomez-Cabrera MC
    Cells; 2022 Sep; 11(19):. PubMed ID: 36231003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.